Clinical Trial Update: Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients With Haemophilia A and Inhibitors

View source ↗

Summary

This clinical trial update describes a case-control pilot study assessing the immune-modulating effect of FEIBA in patients with severe Hemophilia A who have in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• FEIBA (activated prothrombin complex concentrate)

Snippet

Sponsor: Hospital Universitario La Paz | Conditions: Severe Haemophilia A With Inhibitors | Status: UNKNOWN